he chemical class known as FEZ1 inhibitors constitutes a specialized group of compounds that have been meticulously designed and synthesized to interact with a specific target within the cellular environment. At the heart of this class lies the FEZ1 protein, also known as ZMYND8, which exerts its influence over a spectrum of fundamental cellular processes, most notably gene expression regulation. A distinctive feature of FEZ1 is its inclusion of a structural motif called a bromodomain. This bromodomain serves as a key molecular module that possesses the ability to recognize and bind with remarkable specificity to acetylated histones, a crucial event in the orchestration of gene transcription.
FEZ1 inhibitors are strategically engineered molecules that are strategically intended to bind to and modulate the activity of the bromodomain within the FEZ1 protein. Through this molecular interaction, these inhibitors disrupt the natural engagement between the bromodomain and acetylated histones. The precise disruption of this interaction consequently disrupts the intricate chain of events that governs gene transcription regulation, a process integral to the functioning and fate of cells. Characterized by their distinct structural features and chemical properties, FEZ1 inhibitors showcase an impressive degree of selectivity for the bromodomain of FEZ1. This specificity is pivotal in ensuring that these inhibitors have a targeted impact on the protein's function while minimizing any unintended interference with other cellular processes. Through this selective engagement, FEZ1 inhibitors provide researchers with a powerful tool to dissect and explore the intricate landscape of gene expression control, offering a lens into the inner workings of cells at a molecular level. The development and utilization of FEZ1 inhibitors represent a pivotal advancement in the field of molecular biology and chemical biology. These inhibitors offer researchers an avenue to unravel the complexities of gene regulation, as they delve into the nuanced interactions that shape cellular behavior.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PFI 3 | 1819363-80-8 | sc-507340 | 10 mg | $300.00 | ||
PFI-3 is a selective chemical inhibitor of the Fez1 protein. It targets the Fez1's bromodomain, which is involved in recognizing acetylated histones and regulating gene expression. | ||||||
UNC 1215 | 1415800-43-9 | sc-475020 | 10 mg | $380.00 | ||
UNC1215 is another inhibitor targeting the bromodomain of FezIt has shown potential for inhibiting Fez1's binding to acetylated histones, which could influence gene transcription. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
A-485 is a compound that targets multiple bromodomains, including the one present in FezIt is being investigated for its potential to modulate gene expression and potentially impact cancer cell growth. | ||||||
(S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide | 202590-98-5 | sc-501130 | 2.5 mg | $330.00 | ||
Selinexor is an inhibitor that targets nuclear export protein XPOThis indirectly impacts Fez1's function since XPO1-mediated nuclear export plays a role in controlling Fez1's activity. | ||||||
MS417 | 916489-36-6 | sc-507505 | 5 mg | $228.00 | ||
MS417 is an inhibitor that targets multiple bromodomains, including Fez1's. It is being explored for its potential as an epigenetic modulator. | ||||||
RVX 208 | 1044870-39-4 | sc-472700 | 10 mg | $340.00 | ||
RVX-208 is an inhibitor that primarily targets bromodomain-containing protein 4 (BRD4), but it might also have some interactions with Fez1's bromodomain. | ||||||